Clinical laboratory tests showed mild hyperammonemia (133 μmol/L), elevated aspartate, and alanine aminotransferases and alkaline phosphatase (SGOT 172 IU/L, SGPT 86 IU/L, and ALP 687 IU/L), elevated alanine aminotransferase (ALT 161 IU/L), severe metabolic acidosis (pH 7.08, pO2 115 mmHg, and HCO3 2.3 mmol/L), and hypoglycemia. The gene discussed is GPT; the disease is Hyperammonemia.